In-Lab Testing: Device to Reduce Risk of IV Site Infiltrations
Overview
An infiltration at the IV site, when fluid enters tissue outside vessels, is a common problem. Left untreated and unchecked, IV infiltration can lead to excessive fluid in compartments of the arm, causing damage to nerves, arteries, and muscles.
Most facilities rely on a periodic clinician examination of the IV site to determine if an infiltration has occurred. A new optical sensor technology is now available to support the clinical examination with continuous IV site monitoring that claims to provide an early warning of a potential infiltration.
Join our lab tour to learn about infiltration detectors and to get a sneak peek of ECRI's lab testing with this new monitoring technology.
Learning objectives:
During this session, we'll discuss:
- The risk of infiltration
- How the device works
- How we are testing the device
Register to view the recording
Agenda & Speakers
Jason Launders
Director of Operations, Device Evaluation, ECRI
Jason Launders has served ECRI since 1998, and is currently the Director of Operations for the Device Evaluation group. Jason’s primary responsibility is managing ECRI’s laboratory-based evaluations of medical technologies. Jason holds an MSc in Medical Physics, and spent his earlier time at ECRI evaluating a wide range of diagnostic imaging technology, such as: CT, MRI, PACS, and Digital Radiography. Today, he is responsible for developing the content of evaluations to ensure they meet the needs of our members.
Juuso Leinonen, BEng
Principal Project Engineer, Health Devices, ECRI
Juuso Leinonen is a principal project engineer for the Device Evaluation group at ECRI, where he performs comparative medical device evaluations and investigates medical device related accidents. Juuso has over 8 years of experience in biomedical engineering. He has published several ECRI evaluations, guidance articles, and medical device hazard reports in his areas of expertise, which include medical device cybersecurity, infusion technology, pharmacy technologies, and telehealth. Juuso holds a bachelor’s degree in biomedical engineering from City University London, United Kingdom.
Kelly Graham, BS, RN
Patient Safety Analyst IV, ECRI and the Institute for Safe Medication Practices PSO
Kelly Graham has 20 years’ experience in Nursing and Patient Safety. She joined ECRI and the Institute for Safe Medication Practices Patient Safety Organization in 2009. In her current role, Kelly supports healthcare organizations across the country as they work to improve safety and reduce risk. She has published articles on physiologic monitoring safety in various publications and is a clinical representative for ECRI’s Health Devices group.